Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1985 Jan;31:77–81.

Immunization in Canada: Current Controversies

Roy West
PMCID: PMC2327328  PMID: 21279146

Abstract

Immunization, once used solely to control a disease, is now sufficiently widespread that elimination or even eradication of certain diseases has become possible. However, with greater control of disease, adverse reaction to immunization has taken on new prominence. Reporting of adverse reactions varies widely across Canada, and may be due to administrative differences—some provinces rely mostly on the public sector for immunizations, others on the private sector. Several controversies over immunizing agents remain, for example, live versus killed poliovirus vaccine, but generally immunization in Canada is now relatively uniform and safe.

Keywords: Immunization, adverse reaction, prevention

Full text

PDF
77

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernier R. H., Frank J. A., Jr, Nolan T. F., Jr Abscesses complicating DTP vaccination. Am J Dis Child. 1981 Sep;135(9):826–828. doi: 10.1001/archpedi.1981.02130330036011. [DOI] [PubMed] [Google Scholar]
  2. Burridge M. J., Baer G. M., Sumner J. W., Sussman O. Intradermal immunization with human diploid cell rabies vaccine. Serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine. JAMA. 1982 Oct 1;248(13):1611–1614. [PubMed] [Google Scholar]
  3. Fazekas de St Groth Evolution and hierarchy of influenza viruses. Arch Environ Health. 1970 Sep;21(3):293–303. doi: 10.1080/00039896.1970.10667241. [DOI] [PubMed] [Google Scholar]
  4. Karzon D. T. Immunization of public trial. N Engl J Med. 1977 Aug 4;297(5):275–277. doi: 10.1056/NEJM197708042970511. [DOI] [PubMed] [Google Scholar]
  5. Melnick J. L. Advantages and disadvantages of killed and live poliomyelitis vaccines. Bull World Health Organ. 1978;56(1):21–38. [PMC free article] [PubMed] [Google Scholar]
  6. Miller D. L., Ross E. M., Alderslade R., Bellman M. H., Rawson N. S. Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) 1981 May 16;282(6276):1595–1599. doi: 10.1136/bmj.282.6276.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nicholson K. G., Prestage H., Cole P. J., Turner G. S., Bauer S. P. Multisite intradermal antirabies vaccination. Immune responses in man and protection of rabbits against death from street virus by postexposure administration of human diploid-cell-strain rabies vaccine. Lancet. 1981 Oct 24;2(8252):915–918. doi: 10.1016/S0140-6736(81)91402-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nottenbart H. C., Jr Immunizations: risks and warnings about them. Infect Control. 1981 May-Jun;2(3):265–267. [PubMed] [Google Scholar]
  9. Preston N. W. Toxicity of pertussis vaccine. Br Med J (Clin Res Ed) 1982 Jun 19;284(6332):1817–1818. doi: 10.1136/bmj.284.6332.1817-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES